Central neurocytoma with unusually intense FDG uptake: Case report

被引:10
作者
Ohtani, T
Takahashi, A
Honda, F
Ishiuchi, S
Kurihara, H
Inoue, T
Nakazato, Y
Sasaki, T
机构
[1] Gunma Univ, Sch Med, Dept Neurosurg, Maebashi, Gumma 3718511, Japan
[2] Gunma Univ, Sch Med, Dept Nucl Med, Maebashi, Gumma 3718511, Japan
[3] Gunma Univ, Sch Med, Dept Pathol 1, Maebashi, Gumma 3718511, Japan
关键词
central neurocytoma; 2-[fluorine-18]fluoro-2-deoxy-D-glucose; positron emission tomography; MIB-1 labeling index;
D O I
10.1007/BF02988610
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Central neurocytoma is a benign neuronal tumor with a favorable prognosis. This tumor is typically characterized by decreased uptake of F-18-fluorodeoxy glucose (FDG) and any increased uptake of FDG in patients suffering from this tumor would be highly unusual. A case of central neurocytoma with an intense FDG uptake, combined with atypical histopathological features and a high proliferation index is reported in this paper. A 45-year-old male had a two months' history of right hemiweakness. Magnetic resonance (MR) imaging showed a large tumor in the right lateral ventricle. Positron emission tomography (PET) with FDG revealed high glucose metabolism in the tumor. The histological diagnosis was central neurocytoma with atypical features characterized by microvascular proliferation. The MIB-1 labeling index, ordinarily smaller than 2.0%, was 7.0%. Conventional radiotherapy. with a total dose of 50 Gy, was administered after the surgical treatment. The patient returned to his normal daily activities after the cessation of radiation therapy.
引用
收藏
页码:161 / 165
页数:5
相关论文
共 25 条
[1]   Computer tomography and magnetic resonance imaging of a central neurocytoma [J].
Freund, M ;
Lansen, O ;
Geletneky, K ;
Hahnel, S ;
Sartor, K .
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 1998, 168 (05) :502-507
[2]   Proliferative activity of central neurocytoma: Measurement of tumor volume doubling time, MIB-1 staining index and bromodeoxyuridine labeling index [J].
Fujimaki, T ;
Matsuno, A ;
Sasaki, T ;
Toyoda, T ;
Matsuura, R ;
Ogai, M ;
Kitanaka, C ;
Asai, A ;
Matsutani, M ;
Kirino, T .
JOURNAL OF NEURO-ONCOLOGY, 1997, 32 (02) :103-109
[3]   General case of the day [J].
Goldstein, JH ;
Haas, RA ;
Tung, GA .
RADIOGRAPHICS, 1996, 16 (04) :971-973
[4]   CENTRAL NEUROCYTOMA - PROLIFERATIVE ASSESSMENT BY NUCLEOLAR ORGANIZER REGION STAINING [J].
HARA, A ;
ARAKI, Y ;
SHINODA, J ;
HIRAYAMA, H ;
NIIKAWA, S ;
SAKAI, N ;
YAMADA, H .
SURGICAL NEUROLOGY, 1993, 39 (05) :343-347
[5]   CENTRAL NEUROCYTOMA - AN ELECTRON-MICROSCOPIC STUDY OF 2 CASES [J].
HASSOUN, J ;
GAMBARELLI, D ;
GRISOLI, F ;
PELLET, W ;
SALAMON, G ;
PELLISSIER, JF ;
TOGA, M .
ACTA NEUROPATHOLOGICA, 1982, 56 (02) :151-156
[6]   Accuracy of standardized uptake value measured by simultaneous emission and transmission scanning in PET oncology [J].
Inoue, T ;
Oriuchi, N ;
Kunio, M ;
Tomiyoshi, K ;
Tomaru, Y ;
Aoyagi, K ;
Amano, S ;
Suzuki, H ;
Aoki, J ;
Sato, T ;
Endo, K .
NUCLEAR MEDICINE COMMUNICATIONS, 1999, 20 (09) :849-857
[7]  
Kim DG, 1997, CANCER, V79, P1995, DOI 10.1002/(SICI)1097-0142(19970515)79:10<1995::AID-CNCR22>3.0.CO
[8]  
2-P
[9]  
KLEIHUES P, 2000, PATHOLOGY GENETICS T, P107
[10]  
Mackenzie IRA, 1999, CANCER, V85, P1606, DOI 10.1002/(SICI)1097-0142(19990401)85:7<1606::AID-CNCR24>3.0.CO